vs
爱德华生命科学（EW）与Liberty Global Ltd.（LBTYA）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Liberty Global Ltd.的1.3倍（$1.6B vs $1.2B），爱德华生命科学净利率更高（23.1% vs -237.0%，领先260.1%），Liberty Global Ltd.同比增速更快（187.2% vs 16.7%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -20.4%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
自由全球有限公司是一家英荷美合资的跨国电信企业，注册地位于百慕大，在伦敦、阿姆斯特丹和丹佛均设有总部。公司旗下拥有英国自由全球控股有限公司、荷兰自由全球有限公司及美国自由全球公司三大主体，其中英国主体为上市实体。企业由自由媒体国际业务部与UnitedGlobalCom于2005年合并成立，在全球电信服务领域拥有深厚的行业积累。
EW vs LBTYA — 直观对比
营收规模更大
EW
是对方的1.3倍
$1.2B
营收增速更快
LBTYA
高出170.5%
16.7%
净利率更高
EW
高出260.1%
-237.0%
两年增速更快
EW
近两年复合增速
-20.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $380.7M | $-2.9B |
| 毛利率 | 78.0% | 66.8% |
| 营业利润率 | 1.8% | -8.6% |
| 净利率 | 23.1% | -237.0% |
| 营收同比 | 16.7% | 187.2% |
| 净利润同比 | 6.8% | -230.0% |
| 每股收益（稀释后） | $0.66 | $-8.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWLBTYA
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $-1.4B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.4B | $1.9B |
净利润EWLBTYA
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $-2.9B | ||
| Q3 25 | $291.1M | $-90.7M | ||
| Q2 25 | $333.2M | $-2.8B | ||
| Q1 25 | $358.0M | $-1.3B | ||
| Q4 24 | $385.6M | $2.2B | ||
| Q3 24 | $3.1B | $-1.4B | ||
| Q2 24 | $366.3M | $268.1M |
毛利率EWLBTYA
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 66.8% | ||
| Q3 25 | 77.8% | 67.5% | ||
| Q2 25 | 77.5% | 63.3% | ||
| Q1 25 | 78.7% | 65.6% | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | 69.4% | ||
| Q2 24 | 79.9% | 68.5% |
营业利润率EWLBTYA
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | -8.6% | ||
| Q3 25 | 19.8% | -0.7% | ||
| Q2 25 | 26.8% | 2.3% | ||
| Q1 25 | 27.9% | 5.2% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 25.9% | 5.2% | ||
| Q2 24 | 26.8% | 1.0% |
净利率EWLBTYA
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | -237.0% | ||
| Q3 25 | 18.7% | -7.5% | ||
| Q2 25 | 21.7% | -220.1% | ||
| Q1 25 | 25.3% | -114.2% | ||
| Q4 24 | 27.8% | -158.9% | ||
| Q3 24 | 226.7% | -74.1% | ||
| Q2 24 | 26.7% | 14.3% |
每股收益（稀释后）EWLBTYA
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $-8.66 | ||
| Q3 25 | $0.50 | $-0.27 | ||
| Q2 25 | $0.56 | $-8.09 | ||
| Q1 25 | $0.61 | $-3.84 | ||
| Q4 24 | $0.65 | $6.15 | ||
| Q3 24 | $5.13 | $-3.95 | ||
| Q2 24 | $0.61 | $0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.2B |
| 总债务越低越好 | — | $7.8B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | — | $22.6B |
| 负债/权益比越低杠杆越低 | — | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $2.2B | ||
| Q3 25 | $3.8B | $1.7B | ||
| Q2 25 | $4.1B | $3.1B | ||
| Q1 25 | $3.9B | $2.0B | ||
| Q4 24 | $4.0B | $2.2B | ||
| Q3 24 | $4.4B | $3.3B | ||
| Q2 24 | $2.0B | $3.2B |
总债务EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | — | $7.8B | ||
| Q3 25 | — | $7.8B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $8.2B | ||
| Q4 24 | — | $8.2B | ||
| Q3 24 | — | $14.9B | ||
| Q2 24 | — | $14.7B |
股东权益EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $9.7B | ||
| Q3 25 | $10.2B | $12.7B | ||
| Q2 25 | $10.5B | $13.0B | ||
| Q1 25 | $10.1B | $12.6B | ||
| Q4 24 | $10.0B | $12.4B | ||
| Q3 24 | $9.5B | $18.7B | ||
| Q2 24 | $7.4B | $18.3B |
总资产EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $22.6B | ||
| Q3 25 | $13.3B | $25.4B | ||
| Q2 25 | $13.5B | $27.2B | ||
| Q1 25 | $13.0B | $26.0B | ||
| Q4 24 | $13.1B | $25.4B | ||
| Q3 24 | $13.0B | $41.8B | ||
| Q2 24 | $10.1B | $40.8B |
负债/权益比EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | 0.80× | ||
| Q2 24 | — | 0.80× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $630.9M |
| 自由现金流经营现金流 - 资本支出 | — | $193.3M |
| 自由现金流率自由现金流/营收 | — | 15.7% |
| 资本支出强度资本支出/营收 | — | 35.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-132.0M |
8季度趋势，按日历期对齐
经营现金流EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $630.9M | ||
| Q3 25 | $573.7M | $301.8M | ||
| Q2 25 | $290.2M | $149.2M | ||
| Q1 25 | $280.4M | $129.2M | ||
| Q4 24 | $-127.5M | $791.6M | ||
| Q3 24 | $351.8M | $449.5M | ||
| Q2 24 | $371.5M | $546.1M |
自由现金流EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $193.3M | ||
| Q3 25 | $516.2M | $-41.1M | ||
| Q2 25 | $240.9M | $-170.1M | ||
| Q1 25 | $224.4M | $-114.1M | ||
| Q4 24 | $-177.3M | $712.9M | ||
| Q3 24 | $299.9M | $102.4M | ||
| Q2 24 | $286.1M | $256.8M |
自由现金流率EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 15.7% | ||
| Q3 25 | 33.2% | -3.4% | ||
| Q2 25 | 15.7% | -13.4% | ||
| Q1 25 | 15.9% | -9.7% | ||
| Q4 24 | -12.8% | -50.5% | ||
| Q3 24 | 22.1% | 5.3% | ||
| Q2 24 | 20.9% | 13.7% |
资本支出强度EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 35.5% | ||
| Q3 25 | 3.7% | 28.4% | ||
| Q2 25 | 3.2% | 25.2% | ||
| Q1 25 | 4.0% | 20.8% | ||
| Q4 24 | 3.6% | -5.6% | ||
| Q3 24 | 3.8% | 17.9% | ||
| Q2 24 | 6.2% | 15.4% |
现金转化率EWLBTYA
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | -0.33× | 0.35× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 1.01× | 2.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
